A distinct TAM subset mediates immunotherapy resistance in prostate cancer

被引:0
|
作者
Masone, Maria Chiara
机构
[1] Nature Reviews Urology,
关键词
D O I
10.1038/s41585-025-00996-x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:70 / 70
页数:1
相关论文
共 50 条
  • [1] CMA mediates resistance to androgen inhibitors in prostate cancer
    Masone, Maria Chiara
    NATURE REVIEWS UROLOGY, 2023, 20 (03) : 129 - 129
  • [2] CMA mediates resistance to androgen inhibitors in prostate cancer
    Maria Chiara Masone
    Nature Reviews Urology, 2023, 20 : 129 - 129
  • [3] Survivin mediates resistance to antiandrogen therapy in prostate cancer
    Zhang, M
    Latham, DE
    Delaney, MA
    Chakravarti, A
    ONCOGENE, 2005, 24 (15) : 2474 - 2482
  • [4] Survivin mediates resistance to antiandrogen therapy in prostate cancer
    Min Zhang
    Douglas E Latham
    Meaghan A Delaney
    Arnab Chakravarti
    Oncogene, 2005, 24 : 2474 - 2482
  • [5] Evolution of myeloid-mediated immunotherapy resistance in prostate cancer
    Lyu, Aram
    Fan, Zenghua
    Clark, Matthew
    Lea, Averey
    Luong, Diamond
    Setayesh, Ali
    Starzinski, Alec
    Wolters, Rachel
    Arias-Badia, Marcel
    Allaire, Kate
    Wu, Kai
    Gurunathan, Vibha
    Valderrabano, Laura
    Wei, Xiao X.
    Miller, Richard A.
    Van Allen, Eliezer M.
    Fong, Lawrence
    NATURE, 2025, 637 (8048) : 1207 - 1217
  • [6] Immunotherapy of prostate cancer
    Doehn, Christian
    EUROPEAN UROLOGY, 2008, 53 (04) : 681 - 683
  • [7] Immunotherapy for prostate cancer
    Karnes, RJ
    Whelan, CM
    Kwon, ED
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (07) : 807 - 817
  • [8] The immunotherapy of prostate cancer
    Dalgleish, AG
    Perry, MJA
    Eaton, JD
    Hrouda, D
    Todryk, SM
    Kirby, RS
    PROSTATE CANCER AND PROSTATIC DISEASES, 2000, 3 (04) : 303 - 307
  • [9] Immunotherapy for prostate cancer
    Fong, L
    Small, EJ
    SEMINARS IN ONCOLOGY, 2003, 30 (05) : 649 - 658
  • [10] Prostate Cancer Immunotherapy
    Karan, Dev
    Van Veldhuizen, Peter
    CURRENT CANCER THERAPY REVIEWS, 2012, 8 (04) : 237 - 237